CO5570665A2 - Novedosos derivados de piperidina como moduladores del recep tor quimocina ccrs - Google Patents

Novedosos derivados de piperidina como moduladores del recep tor quimocina ccrs

Info

Publication number
CO5570665A2
CO5570665A2 CO05057099A CO05057099A CO5570665A2 CO 5570665 A2 CO5570665 A2 CO 5570665A2 CO 05057099 A CO05057099 A CO 05057099A CO 05057099 A CO05057099 A CO 05057099A CO 5570665 A2 CO5570665 A2 CO 5570665A2
Authority
CO
Colombia
Prior art keywords
alkyl
heteroaryl
cycloalkyl
optionally substituted
halo
Prior art date
Application number
CO05057099A
Other languages
English (en)
Inventor
John Cumming
Alan Wellington Faull
Colin Fielding
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0203821A external-priority patent/SE0203821D0/xx
Priority claimed from SE0300499A external-priority patent/SE0300499D0/xx
Priority claimed from SE0301425A external-priority patent/SE0301425D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CO5570665A2 publication Critical patent/CO5570665A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

1.- Un compuesto de formula (I):en donde:A está ausente o es (CH2)2;R1 es alquilo C1-8, C(O)NR10R11, C(O)2R12, NR13C(O)R14, NR15C(O)NR16R17, NR18C(O)2R19, heterociclilo, arilo o heteroarilo;R10, R13, R15, R16 y R18 son hidrógeno o alquilo C1-6;R11, R12, R14, R17 y R19 son alquilo C1-8 (opcionalmente sustituido por halo, hidroxi, alcoxi C1-6, haloalcoxi C1-6, cicloalquilo C3-6 (opcionalmente sustituido por halo), cicloalquenilo C5-6, S(alquilo C1-4), S(O)(alquilo C1-4), S(O)2(alquilo C1-4), heteroarilo, arilo, heteroariloxi o ariloxi), arilo, heteroarilo, cicloalquilo C3-7 (opcionalmente sustituido por halo o alquilo C1-4), cicloalquilo C4-7 fusionado a un anillo fenilo, cicloalquenilo C5-7, o, heterociclilo (a su vez opcionalmente sustituido por oxo, C(O)(alquilo C1-6), S(O)k(alquilo C1-6), halo o alquilo C1-4); o R11, R12, R14 y R17 también pueden ser hidrógeno;o R10 y R11, y/o R16 y R17 pueden unirse para formar un anillo de 4-, 5- o 6 miembros que incluye opcionalmente un átomo de nitrógeno, oxígeno o azufre, estando dicho anillo opcionalmente sustituido por alquilo C1-6, S(O)I(alquilo C1-6) o C(O)(alquilo C1-6);R2 es alquilo C1-6, fenilo, heteroarilo o cicloalquilo C3-7;R3 es H o alquilo C1-4;R4 es arilo, heteroarilo, alquilo C1-6 o cicloalquilo C3-7;X es O o S(O)p;m y n son, independientemente, 0, 1, 2 o 3, siempre y cuando m + n es 1 o más;las mitades arilo, fenilo y heteroarilo están independientemente opcionalmente sustituidas por uno o más de halo, ciano, nitro, hidroxi, OC(O)NR20R21, NR22R23, NR24C(O)R25, NR26C(O)NR27R28, S(O)2NR29R30, NR31S(O)2R32, C(O)NR33R34, CO2R36, NR37CO2R38, S(O)qR39, OS(O)2R49, alquilo C1-6 (opcionalmente mono-sustituido por S(O)2R50 o C(O)NR51R52), alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-10, haloalquilo C1-6, alcoxiC1-6alquilo(C1-6), alcoxi C1-6(opcionalmente mono-sustituido por CO2R53, C(O)NR54R55, ciano, heteroarilo o C(O)NHS(O)2R56), NHC(O)NHR57, haloalcoxi C1-6, fenilo, feniloalquilo(C1-4), fenoxi, feniltio, feniIS(O), feniIS(O)2, ...
CO05057099A 2002-12-20 2005-06-13 Novedosos derivados de piperidina como moduladores del recep tor quimocina ccrs CO5570665A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0203821A SE0203821D0 (sv) 2002-12-20 2002-12-20 Chemical Compounds
SE0300499A SE0300499D0 (sv) 2003-02-24 2003-02-24 Chemical compounds
SE0301425A SE0301425D0 (sv) 2003-05-15 2003-05-15 Chemical compounds

Publications (1)

Publication Number Publication Date
CO5570665A2 true CO5570665A2 (es) 2005-10-31

Family

ID=32685861

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05057099A CO5570665A2 (es) 2002-12-20 2005-06-13 Novedosos derivados de piperidina como moduladores del recep tor quimocina ccrs

Country Status (17)

Country Link
US (1) US20060189650A1 (es)
EP (1) EP1572650A1 (es)
JP (1) JP2006514107A (es)
KR (1) KR20050084424A (es)
AR (1) AR042628A1 (es)
AU (1) AU2003288856B2 (es)
BR (1) BR0317459A (es)
CA (1) CA2508624A1 (es)
CL (1) CL2003002678A1 (es)
CO (1) CO5570665A2 (es)
IS (1) IS7942A (es)
MX (1) MXPA05006381A (es)
NZ (1) NZ540780A (es)
PL (1) PL377768A1 (es)
TW (1) TW200505856A (es)
UY (1) UY28139A1 (es)
WO (1) WO2004056773A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301369D0 (sv) * 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
SE0302090D0 (sv) * 2003-07-16 2003-07-16 Astrazeneca Ab Chemical compounds
ATE361911T1 (de) * 2003-07-31 2007-06-15 Astrazeneca Ab Piperidinderivate als ccr5-rezeptormodulatoren
TW200610761A (en) * 2004-04-23 2006-04-01 Astrazeneca Ab Chemical compounds
CN101001860A (zh) 2004-06-09 2007-07-18 霍夫曼-拉罗奇有限公司 杂环抗病毒化合物
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
SE0401657D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
US7665658B2 (en) 2005-06-07 2010-02-23 First Data Corporation Dynamic aggregation of payment transactions
CN101291905A (zh) 2005-10-19 2008-10-22 弗·哈夫曼-拉罗切有限公司 苯乙酰胺nnrt抑制剂
KR101401811B1 (ko) 2006-08-16 2014-05-29 에프. 호프만-라 로슈 아게 비-뉴클레오사이드 역전사효소 저해제
WO2008039999A1 (en) * 2006-09-28 2008-04-03 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
RU2469032C2 (ru) 2006-12-13 2012-12-10 Ф.Хоффманн-Ля Рош Аг Производные 2-(пиперидин-4-ил)-4-фенокси- или фениламинопиримидина в качестве ненуклеозидных ингибиторов обратной транскриптазы
UY33110A (es) 2009-12-23 2011-07-29 Ironwood Pharmaceuticals Inc Moduladores de CRTH2
US20130259830A1 (en) 2010-07-12 2013-10-03 Ironwood Pharmaceuticals, Inc. Crth2 modulators
WO2012009137A1 (en) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Crth2 modulators
WO2018068296A1 (en) * 2016-10-14 2018-04-19 Merck Sharp & Dohme Corp. PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
CN113444065A (zh) * 2021-06-29 2021-09-28 浙江得乐康食品股份有限公司 一种莽草酸磺化物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
EP1013276A1 (en) * 1998-12-23 2000-06-28 Pfizer Inc. Aminoazacycloalkanes as CCR5 modulators
US6432981B1 (en) * 1999-06-11 2002-08-13 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0108046D0 (en) * 2001-03-30 2001-05-23 Astrazeneca Ab Chemical compounds
EP1467986A1 (en) * 2002-01-17 2004-10-20 Eli Lilly And Company Aza-cyclic compounds as modulators of acetylcholine receptors

Also Published As

Publication number Publication date
PL377768A1 (pl) 2006-02-20
TW200505856A (en) 2005-02-16
WO2004056773A1 (en) 2004-07-08
KR20050084424A (ko) 2005-08-26
JP2006514107A (ja) 2006-04-27
AR042628A1 (es) 2005-06-29
UY28139A1 (es) 2004-07-30
BR0317459A (pt) 2005-11-16
EP1572650A1 (en) 2005-09-14
MXPA05006381A (es) 2005-08-29
IS7942A (is) 2005-07-18
NZ540780A (en) 2008-04-30
CA2508624A1 (en) 2004-07-08
AU2003288856B2 (en) 2006-11-16
US20060189650A1 (en) 2006-08-24
AU2003288856A1 (en) 2004-07-14
CL2003002678A1 (es) 2005-04-22

Similar Documents

Publication Publication Date Title
CO5570665A2 (es) Novedosos derivados de piperidina como moduladores del recep tor quimocina ccrs
AR069596A1 (es) Regulador del crecimiento de plantas
AR087119A1 (es) Composiciones plaguicidas y procesos relacionados
PE20090226A1 (es) PIRROLIDINAMIDAS SUSTITUIDAS COMO INHIBIDORES DEL FACTOR Xa Y SU PREPARACION
AR061548A1 (es) 3-aminopirrolidino-4-lactamas sustituidas como inhibidoras de dipeptidilpeptidasa iv (dpp-iv), composiciones farmaceuticas que las comprenden y el uso de las mismas en el tratamiento de la diabetes ii.
PE20090449A1 (es) Agonistas de receptor acoplado a proteina g gpr119 de piridona
AR048641A1 (es) Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame
AR077818A1 (es) Composiciones pesticidas
UA95255C2 (en) Azole and thiazole derivatives and their use
EA201070782A1 (ru) Производные оксадиазола, активные в отношении сфингозин-1-фосфата(sip)
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
RU2014129742A (ru) Производные бензолсульфонамида в качестве модуляторов rorc
AR019486A1 (es) Compuesto derivado de benzoxazol, benzotiazol y bencimidazol; procesos para prepararlo; composiciones que lo comprenden, metodos para combatir y controlar hongos e insectos, acaros, nematodos y moluscos.
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
AR089875A1 (es) Composiciones plaguicidas y procesos relacionados con dichas composiciones
AR091710A1 (es) Composiciones pesticidas y procesos relacionados con las mismas
AR087467A1 (es) Compuesto heterociclico fusionado y su uso para el control de plagas
AR004002A1 (es) Composicion util especialmente para el tratamiento y la proteccion de los animales domesticos infestados o susceptibles de ser infestados por parasitos
CO6210724A2 (es) Compuesto heterociclico y composicion farmaceutica del mismo
CO5231190A1 (es) Combinaciones de compuestos activos del tipo de los cetoenoles ciclicos con piretroides
AR070503A1 (es) Compuesto de organoazufre con contenido de halogeno, una composicion pesticida y su uso para control de plagas
MY148980A (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
CO5031250A1 (es) Compuesto farmaceutico
BR0312882A (pt) Derivados de pleuromutilina como antimicrobianos
PE20120657A1 (es) Compuesto para el tratamiento de trastornos metabolicos

Legal Events

Date Code Title Description
FC Application refused